Naltrexone Extended Release Linked To Lower Rates of Opioid-Use Relapse

Naltrexone Implants

April 01, 2016 Extended-release naltrexone releases medicine to block the euphoric effects of opioids for 1 month following injection in most patients. A new study examined naltrexone’s effects among adult offenders with a history of opioid dependence. Extended-release naltrexone releases medicine to block the euphoric effects of opioids for 1 month following injection in most patients. A new study examined naltrexone’s effects among adult offenders with a history of opioid dependence. For the five-site, open-label, randomized trial, 153 participants received a 24-week course of extended-release naltrexone, while 155 individuals received…

Read More